Workflow
BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor
CybinCybin(US:CYBN) Thenewswire·2025-10-21 12:00

  VANCOUVER, British Columbia, October 21, 2025 – TheNewswire - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed Doug Drysdale, former CEO of Cybin Inc. (“Cybin”) (NYSE: CYBN) as Corporate Advisor to advance BetterLife’s product BETR-001’s non psychiatric indications with focus on cluster headache and migraine.  At Cybin, Mr. Drysdale led the company’s strategy and team build-out, taking it from ...